BOLD
Boundless Bio, Inc.
2.46
+0.01 (+0.41%)
52w low 0.9610
3.16 high
68.0% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | -- | 14.70M | 14.98M | 17.87M | 17.48M | 20.21M | |
| Current Assets | -- | 129.69M | 120.16M | 109.61M | 94.62M | 73.65M | |
| Net PP&E | -- | 49.16M | 47.98M | 46.88M | 45.77M | 97.00K | |
| Total Assets | -- | 179.45M | 168.72M | 157.06M | 140.97M | 73.74M | |
| Current Liabilities | -- | 9.21M | 11.85M | 12.54M | 9.58M | 7.77M | |
| Total Debt | -- | 49.51M | 49.76M | 49.03M | 48.29M | 0.00 | |
| Total Liabilities | -- | 56.76M | 58.55M | 58.41M | 54.59M | 7.77M | |
| Retained Earnings | -- | -232.91M | -246.78M | -259.67M | -273.22M | -296.92M | |
| Shareholders Equity | -- | 122.69M | 110.17M | 98.65M | 86.38M | 65.98M | |
| Working Capital | -- | 120.48M | 108.31M | 97.07M | 85.03M | 65.88M | |
| Shares Outstanding | -- | 22.39M | 22.39M | 22.41M | 22.41M | 22.48M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--